Fri, 19 Oct 2012Early stage drug development company Redx Pharma will create 119 direct jobs and support a further 28 in its wider supply chain over two years, thanks to a £4.7m grant from the Department for Business, Innovation and Skills’ (BIS’s) Regional Growth Fund (RGF).

Redx is based at the University of Liverpool and describes the direct jobs as “high value science jobs”, while those in the supply chain are labelled “specialist”.

The firm previously received money from the same fund for another spin out company, cancer research and development arm Redx Oncology, which currently employs more than 50 people in Liverpool.

Dr Neil Murray, chief executive at Redx, comments: “The World Health Organisation has identified drug resistance, particularly in the area of antibiotics, as one of the most pressing human health concerns globally. We believe that the fresh thinking and original approach that we apply will create effective solutions, generating new therapies that will benefit patients worldwide.”

A total of £2.4bn RGF money is to be allocated across England between 2011 and 2015, with the current third round of awards benefiting 130 projects and organisations selected from 414 bids.